While final details may continue to evolve, individuals may qualify if they meet the following general requirements: Enrollment in Medicare Part D or a Medicare Advantage plan that includes prescription drug coverage A determination by their physician that a GLP-1 medication is appropriate Meeting defined health criteria, such as obesity or certain related conditions Approval of a prior authorization request submitted by their doctor It is important to understand that not all beneficiaries will qualify for the program
N Engl J Med 2019;380:2295306.PubMed 47
Human Pharmacokinetic and Clinical Data Although this article focuses on in-vitro and laboratory-animal research, ipamorelin has been studied in humans
Now its worth clarifying a lot of medication has a side effect, so this is not for us to be berating GLP-1 use
They both have the advantage of being active and bioavailable to the body
R., Lingvay, I., Ldemann, J., Andreassen, C., Navarria, A., & Viljoen, A